Top Markets
Coin of the day
Aelis Farma S.A. Aelis Farma S.A.

Aelis Farma S.A.

AELIS
Classement en actions #30387
Aelis Farma S.A., a French biotechnology company founded in 2013 and... Aelis Farma S.A., a French biotechnology company founded in 2013 and headquartered in Bordeaux, is dedicated to the discovery and development of treatments for brain-related illnesses. The firm's research pipeline primarily focuses on signaling-specific inhibitors that target CB1 receptors. Its leading investigational drug, AEF0117, is currently advancing through Phase 2b clinical trials, designed to alleviate the harmful impacts of excessive cannabis consumption. Furthermore, AEF0217, another key drug candidate, has successfully completed Phase 1 clinical trials, with the goal of addressing cognitive impairments linked to Down syndrome and other similar conditions.
Prix de l'action
$1.25
Dernière synchronisation: 2026-08-18
Capitalisation boursière
$17.05M
Changement (1 jour)
-1.50%
Changement (1 an)
-22.24%
Pays
FR
Échange Aelis Farma S.A. (AELIS)

Catégorie

Ratio P/B pour Aelis Farma S.A. (AELIS)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Aelis Farma S.A., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Aelis Farma S.A. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH
3.4612 -
BE